Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Multidisciplinary teams for the proper management of patients with genitourinary tumors: When topics set scientific societies' agenda.

Magnani T, Bracarda S, D'Angelillo RM, Artibani W, Barni S, Beretta G, Brausi M, Caffo O, Corvò R, Gallucci M, Gunelli R, Mirone V, Novara G, Pinto C, Russi E, Santoni R, Tomirotti M, Volpe A, Conti G, Valdagni R.

Tumori. 2019 Apr;105(2):161-167. doi: 10.1177/0300891618784789. Epub 2018 Jul 5.

PMID:
29974825
2.

Conflict of interest among Italian medical oncologists: a national survey.

DeCensi A, Numico G, Ballatori E, Artioli F, Clerico M, Fioretto L, Livellara V, Ruggeri B, Tomirotti M, Verusio C, Roila F; Italian College of Chief Medical Oncologists (CIPOMO).

BMJ Open. 2018 Jun 30;8(6):e020912. doi: 10.1136/bmjopen-2017-020912.

3.

Temporary ovarian suppression during chemotherapy to preserve ovarian function and fertility in breast cancer patients: A GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

Lambertini M, Cinquini M, Moschetti I, Peccatori FA, Anserini P, Valenzano Menada M, Tomirotti M, Del Mastro L.

Eur J Cancer. 2017 Jan;71:25-33. doi: 10.1016/j.ejca.2016.10.034. Epub 2016 Dec 9. Review.

PMID:
27940355
4.

Secondary breast angiosarcoma and paclitaxel-dependent prolonged disease control: report of two cases and review of the literature.

Gambini D, Visintin R, Locatelli E, Bareggi C, Galassi B, Runza L, Blundo C, Sosnovskikh I, Tomirotti M.

Tumori. 2015 Apr 28;101(2):e60-3. doi: 10.5301/tj.5000252. Review.

PMID:
25744864
5.

Sunitinib-induced complete response in metastatic renal cancer expressing neuroendocrine markers: a new predictive factor?

Gambini D, Locatelli E, Gianelli U, Bareggi C, Galassi B, Visintin R, Massironi S, Dell'orto PG, Tomirotti M.

Anticancer Res. 2014 Dec;34(12):7361-5.

PMID:
25503173
6.

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial.

Garassino MC, Martelli O, Broggini M, Farina G, Veronese S, Rulli E, Bianchi F, Bettini A, Longo F, Moscetti L, Tomirotti M, Marabese M, Ganzinelli M, Lauricella C, Labianca R, Floriani I, Giaccone G, Torri V, Scanni A, Marsoni S; TAILOR trialists.

Lancet Oncol. 2013 Sep;14(10):981-8. doi: 10.1016/S1470-2045(13)70310-3. Epub 2013 Jul 22.

PMID:
23883922
7.

Remission of autoimmune hyperthyroidism after chemotherapy for cancer.

Baldini M, Gambini D, Airaghi L, Tomirotti M, Cappellini MD.

Intern Emerg Med. 2014 Feb;9(1):109-11. doi: 10.1007/s11739-013-0937-7. Epub 2013 Apr 9. No abstract available.

PMID:
23568316
8.

Uncommon breast malignancies: presentation pattern, prognostic issue and treatment outcome in an Italian single institution experience.

Bareggi CM, Consonni D, Galassi B, Gambini D, Locatelli E, Visintin R, Runza L, Giroda M, Sfondrini MS, Onida F, Tomirotti M.

Tumori. 2013 Jan-Feb;99(1):39-44. doi: 10.1700/1248.13786.

PMID:
23548998
9.

Level of HER2/neu amplification in primary tumours and metastases in HER2-positive breast cancer and survival after trastuzumab therapy.

Gullo G, Bettio D, Zuradelli M, Masci G, Giordano L, Bareggi C, Tomirotti M, Salvini P, Runza L, La Verde N, Santoro A.

Breast. 2013 Apr;22(2):190-193. doi: 10.1016/j.breast.2013.01.005. Epub 2013 Mar 7.

10.

Rationale for treatment and study design of tailor: a randomized phase III trial of second-line erlotinib versus docetaxel in the treatment of patients affected by advanced non-small-cell lung cancer with the absence of epidermal growth factor receptor mutations.

Farina G, Longo F, Martelli O, Pavese I, Mancuso A, Moscetti L, Labianca R, Bertolini A, Cortesi E, Farris A, Fagnani D, Locatelli MC, Valmadre G, Ardizzoia A, Tomirotti M, Rulli E, Garassino MC, Scanni A.

Clin Lung Cancer. 2011 Mar;12(2):138-41. doi: 10.1016/j.cllc.2011.03.008. Epub 2011 Apr 11.

PMID:
21550561
11.

Paclitaxel-dependent prolonged and persistent complete remission four years from first recurrence of secondary breast angiosarcoma.

Gambini D, Visintin R, Locatelli E, Galassi B, Bareggi C, Runza L, Onida F, Tomirotti M.

Tumori. 2009 Nov-Dec;95(6):828-31.

PMID:
20210253
12.

The impact of antithrombotic prophylaxis on infectious complications in cancer patients with central venous catheters: an observational study.

Fagnani D, Bertolini A, Catena L, Tomirotti M, Visini M, Alatri A, De Paoli A, Aondio GM, Milani M, Arpaia G, Cimminiello C; POLONORD Group, Franchi R, Porta C, Pugliese P, Borgonovo K, Duro M, Ardizzoia A, Filipazzi V, Isa L, Vergani C, Carpenedo M, Viale P.

Blood Coagul Fibrinolysis. 2009 Jan;20(1):35-40. doi: 10.1097/MBC.0b013e32831bc2f8.

PMID:
20523163
13.

Cetuximab-induced acneiform eruption and the response to isotretinoin.

Vezzoli P, Marzano AV, Onida F, Alessi E, Galassi B, Tomirotti M, Berti E.

Acta Derm Venereol. 2008;88(1):84-6. doi: 10.2340/00015555-0330. No abstract available.

14.

Combined treatment with high-dose methotrexate, vincristine and procarbazine, without intrathecal chemotherapy, followed by consolidation radiotherapy for primary central nervous system lymphoma in immunocompetent patients.

Ferreri AJ, Reni M, Dell'Oro S, Ciceri F, Bernardi M, Camba L, Ponzoni M, Terreni MR, Tomirotti M, Spina M, Villa E.

Oncology. 2001;60(2):134-40.

PMID:
11244328
15.

Complications of subcutaneous infusion port in the general oncology population.

Ballarini C, Intra M, Pisani Ceretti A, Cordovana A, Pagani M, Farina G, Perrone S, Tomirotti M, Scanni A, Spina GP.

Oncology. 1999;56(2):97-102.

PMID:
9949293
16.

Long-term toxicity in adjuvant treatment with tamoxifen.

Cobelli S, Dambrosio M, Farina G, Rovej R, Tomirotti M, Scanni A.

J Chemother. 1997 Aug;9(4):300-3.

PMID:
9269612
17.

Cis/carboplatin + vinorelbine +/- radiotherapy in stage III and IV non small cell lung carcinoma.

Tomirotti M, Galassi B, Dambrosio M, Fossati V, Gramegna G, Colombo F, Rovej R, Scanni A.

J Chemother. 1997 Feb;9(1):62-5.

PMID:
9106020
19.

Pharmacokinetics and bioavailability of metoclopramide nasal spray versus metoclopramide intravenous in healthy volunteers and cancer patients.

Scaglione F, Scanni A, Tomirotti M, Dimaiuta M, Ferrari P, Fraschini F.

Arzneimittelforschung. 1993 Sep;43(9):986-8.

PMID:
8240464
20.

Recovery of response to adriamycin and cyclophosphamide by lonidamine in previously treated metastatic breast-cancer patients.

Tomirotti M, Bernardo G, Epifani C, Biasioli R, Franchi R, Mensi F, Carnaghi P, Schieppati G, Scanni A.

Int J Oncol. 1993 Aug;3(2):213-7.

PMID:
21573350
21.

Concurrent carboplatin (CBDCA), vindesine (VDS) and radiotherapy in stage III non small cell lung cancer (NSCLC).

Tomirotti M, Gramegna G, Mantellini P, Fossati V, Mezzetti M, Dimaiuta M, Scanni A.

Tumori. 1993 Feb 28;79(1):49-52.

PMID:
8388588
22.

Cisplatin (P) versus cyclophosphamide, adriamycin and cisplatin (CAP) for stage III-IV epithelial ovarian carcinoma: a prospective randomized trial.

Tomirotti M, Perrone S, Giè P, Canaletti R, Carpi A, Biasoli R, Lombardi F, Giovanninetti A, Mensi F, Villa S, et al.

Tumori. 1988 Oct 31;74(5):573-7.

PMID:
3217992
23.

Combination of mitomycin C + etoposide in advanced gastric carcinoma.

Tomirotti M, Lombardi F, Biasioli R, Riundi R, Scanni A.

Tumori. 1985 Aug 31;71(4):371-3.

PMID:
3931320
24.

[Experimental study on the use of cisplatin in oncology].

Scanni A, Tomirotti M, Campolunghi D, Biraghi M, Curtarelli G.

Minerva Med. 1985 Apr 28;76(17-18):851-7. Italian.

PMID:
3889721
25.

Ischemic cardiopathy from cis-diamminedichloroplatinum (CDDP).

Tomirotti M, Riundi R, Pulici S, Ungaro A, Pedretti D, Villa S, Scanni A.

Tumori. 1984 Jun 30;70(3):235-6. No abstract available.

PMID:
6588670
26.

Phase II study of cyclophosphamide and hexamethylmelamine in non-oat cell bronchogenic carcinoma.

Pisoni MB, Libretti A, Piazza E, Vago G, Scapaticci R, Bianchi C, Tomirotti M, Scanni A, Calzavara MP, Cassani L, Scarpazza G, Marsoni S, Morasca L.

Cancer Treat Rep. 1981 Jul-Aug;65(7-8):731-2. No abstract available.

PMID:
6788372
27.

Bleomycin, vincristine, and methotrexate (BOM) in squamous cell carcinoma of the lung: a phase II study.

Libretti A, Piazza E, Scanni A, Tomirotti M, Biraghi M, Scapaticci R, Bianchi C, Restelli G, Scarpazza G, Calzavara MP, Marsoni S, Morasca L.

Cancer Treat Rep. 1981 Jan-Feb;65(1-2):171-2. No abstract available.

PMID:
6164485
28.

Lithium carbonate in the treatment of drug-induced leukopenia in patients with solid tumors.

Scanni A, Tomirotti M, Berra S, Licciardello L, Felicetta I, Bertolini G, Bregni M.

Tumori. 1980 Dec 31;66(6):729-37.

PMID:
7015644
29.

[Behavior of respiratory function during antineoplastic chemotherapy].

Vignali M, Sergi M, Natale N, Scanni A, Trabattoni A, Luerti M, Tomirotti M, Bosisio E.

Minerva Ginecol. 1980 Oct;32(10):899-903. Italian. No abstract available.

PMID:
7432700
30.

[Changes of serum copper concentration during rheumatoid arthritis. Comparison with its behavior in gastric carcinoma].

Scanni A, Tomirotti M, Annibali E.

Minerva Med. 1980 Apr 14;71(15):1123-5. Italian. No abstract available.

PMID:
7375026
31.

[Serum copper as a means of therapeutic monitoring of patients with rheumatoid arthritis].

Scanni A, Trovato M, Tomirotti M.

Minerva Med. 1980 Apr 14;71(15):1115. Italian. No abstract available.

PMID:
7375023
32.

[Cyclophosphamide, methotrexate and 5-fluorouracil (CMF), versus 5-fluorouracil, in carcinoma of the large intestine in an advanced stage].

Scanni A, Tomirotti M, Biraghi M, Annibali E, Del Bianco S.

Minerva Med. 1980 Mar 17;71(10):799-801. Italian. No abstract available.

PMID:
7360368
33.

Variations in serum copper and ceruloplasmin levels in advanced gastrointestinal cancer treated with polychemotherapy.

Scanni A, Tomirotti M, Licciardello L, Annibali E, Biraghi M, Trovato M, Fittipaldi M, Adamoli P, Curtarelli G.

Tumori. 1979 Jun 30;65(3):331-8.

PMID:
462583
34.

Cyclophosphamide, methotrexate, 5-fluorouracil (CMF) in advanced gastrointestinal cancer.

Scanni A, Tomirotti M, Margulis A, Biraghi M, Curtarelli G.

Tumori. 1979 Feb 28;65(1):111-7.

PMID:
87046
35.

[Urinary excretion of flavoxate administered in combination with metamizole].

Scanni A, Tomirotti M, Biraghi M, Cova A.

Boll Chim Farm. 1977 Oct;116(10):584-8. Italian. No abstract available.

PMID:
343796
36.

[Blood concentration and urinary elimination of dimefline after single oral administration in man].

Scanni A, Biraghi M, Tomirotti M, Cova A.

Boll Chim Farm. 1977 Jun;116(6):353-7. Italian. No abstract available.

PMID:
889638
37.

Serum copper and ceruloplasmin levels in patients with neoplasias localized in the stomach, large intestine or lung.

Scanni A, Licciardello L, Trovato M, Tomirotti M, Biraghi M.

Tumori. 1977 Mar-Apr;63(2):175-80.

PMID:
898288

Supplemental Content

Loading ...
Support Center